| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/10/2005 | EP1368052B1 Agents, which inhibit apoptosis in cells that are involved in wound healing |
| 08/10/2005 | EP1123398B1 Molecular pathogenicide mediated plant disease resistance |
| 08/10/2005 | EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 08/10/2005 | EP1051487B1 Placental protein 13 |
| 08/10/2005 | EP0968288B1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a |
| 08/10/2005 | EP0939652B1 Use of antibodies to cd45ro leukocyte antigen for immunomodulation |
| 08/10/2005 | EP0931094B1 Methods for determining the presence of brain protein s-100 beta |
| 08/10/2005 | EP0914344B8 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 08/10/2005 | EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 08/10/2005 | CN1653336A Diagnosis of hepatocellular carcinoma |
| 08/10/2005 | CN1653335A Universal libraries for immunoglobulins |
| 08/10/2005 | CN1653177A Muteins of placental growth factor type 1, preparation method and application thereof |
| 08/10/2005 | CN1653173A Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide |
| 08/10/2005 | CN1653084A Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 08/10/2005 | CN1653080A Lymphatic and blood endothelial cell genes |
| 08/10/2005 | CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA) |
| 08/10/2005 | CN1652820A Methods of treatment using CTLA-4 antibodies |
| 08/10/2005 | CN1652815A Human monoclonal antibodies to influenza M2 protein and methods of making and using same |
| 08/10/2005 | CN1651919A CD154 blockade monoclone antibody use for inhibiting rejection of insulin producing tissue transplantation |
| 08/10/2005 | CN1651458A Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 08/10/2005 | CN1651457A Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
| 08/10/2005 | CN1651071A CD154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/10/2005 | CN1214118C DNA antibody and uses thereof |
| 08/10/2005 | CN1214115C Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
| 08/10/2005 | CN1214044C ErdB3 antibodies |
| 08/10/2005 | CN1214043C Humanized antibodies to gamma-interferon |
| 08/10/2005 | CN1214042C Production process for intravenous immune serum globulin and resultant product |
| 08/09/2005 | US6927281 isolated monoclonal antibody directed against an AAV type 2 capsid or protein, capable of detection in an ELISA assay, immunofluorescence or Western blotting |
| 08/09/2005 | US6927203 Treatment of metastatic disease |
| 08/09/2005 | US6927054 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects |
| 08/09/2005 | US6927044 IL-1 receptor based cytokine traps |
| 08/09/2005 | US6927040 Polpeptide for use in the treatment of granulomatosis, nervous system and skin disorders, bacterial infections and leishmania |
| 08/09/2005 | US6927035 Antigens used for medical diagnosis of dihydropyrimidine dehydrogenase (DPD) deficiency |
| 08/09/2005 | US6927034 Diagnosing pregnancy in humans; obtain sample, incubate with antibody, monitor complex formation, presence of complex indicates pregnancy |
| 08/09/2005 | US6926898 Albumin fusion proteins |
| 08/09/2005 | US6926896 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction |
| 08/09/2005 | US6926894 For the prophylaxis or therapy of thrombosis and thromboembolic diseases |
| 08/09/2005 | US6926893 Multi-stage cascade boosting vaccine |
| 08/09/2005 | US6926888 producer cell ( encapsulated in a matrix which containing alginates) containing a plasmid that includes a nucleic acid sequence that encodes endostatin, angiostatin, thrombospondin, or prolactin |
| 08/09/2005 | US6926408 Continuous two-dimensional corneal topography target |
| 08/09/2005 | CA2289665C Protein recovery by chromatography followed by filtration upon a charged layer |
| 08/09/2005 | CA2150346C Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody |
| 08/09/2005 | CA2109098C Activity-dependent neurotrophic factor |
| 08/06/2005 | CA2553946A1 Antibodies against clostridium difficile toxins and uses thereof |
| 08/04/2005 | WO2005071387A1 Methods for diagnosis and pronosis of cancers of epithelial origin |
| 08/04/2005 | WO2005071075A1 Peptide originating in epidermal growth factor receptor (egfr) |
| 08/04/2005 | WO2005071070A2 Substances directed against specific sequence essential for heparanase catalytic activity end uses thereof as heparanase inhibitors |
| 08/04/2005 | WO2005070967A2 Anti-cancer antibodies with reduced complement fixation |
| 08/04/2005 | WO2005070966A2 Fusion polypeptides capable of activating receptors |
| 08/04/2005 | WO2005070965A2 Pharmaceutical compositions containing antagonists to lrp4, lrp8 or megalin for treatment of diseases |
| 08/04/2005 | WO2005070964A1 Method of isolating monocytes |
| 08/04/2005 | WO2005070963A1 Fc region variants |
| 08/04/2005 | WO2005070962A1 Production of a monoclonal antibody in a heterokaryon fungus or in a fungal host cell |
| 08/04/2005 | WO2005070458A1 Improved iga production method |
| 08/04/2005 | WO2005070456A2 Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies |
| 08/04/2005 | WO2005070126A2 Methods and compositions for treating human diseases and wounds with ucp and fas inhibitors |
| 08/04/2005 | WO2005069970A2 Antibody specificity transfer using minimal essential binding determinants |
| 08/04/2005 | WO2005069935A2 METHODS FOR MEASURING TRANSFORMING GROWTH FACTOR BETA (TGF-β) RECEPTOR SIGNALING ACTIVITY AND USES THEREOF |
| 08/04/2005 | WO2005069906A2 Methods and compositions relating to vascular endothelial growth factor and th2 mediated inflammatory diseases |
| 08/04/2005 | WO2005069717A2 The use os anti-rh antibodies for treating acute thrombocytopenia associated with dengue hemorrhagic fever, hepatitis c and other microbial infections |
| 08/04/2005 | WO2005058865A3 Assay for entactogens |
| 08/04/2005 | WO2005054294A3 Inhibitors of glycoprotein vi based on monoclonal antibody hgp 5c4 |
| 08/04/2005 | WO2005052001A3 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
| 08/04/2005 | WO2005044859A3 Cd20 antibodies with increased fc receptor binding affinity and effector function |
| 08/04/2005 | WO2005037865A3 Ztnfr14, A TUMOR NECROSIS FACTOR RECEPTOR |
| 08/04/2005 | WO2005020891A3 Monoclonal antibodies against ricin toxin and methods of making and using thereof |
| 08/04/2005 | WO2004092360A3 The severe acute respiratory syndrome coronavirus |
| 08/04/2005 | WO2004080385A3 Compositions and methods for diagnosing and treating an inflammation |
| 08/04/2005 | WO2004080273A3 Compositions and methods for diagnosing and treating prostate cancer |
| 08/04/2005 | WO2004053487A8 METHOD OF DIAGNOSIS,TREATMENT AND USEFUL AGENTS FOR CONDITIONS CHARACTERISED BY MODULATION IN THE LEVEL OF ACTIVIN βC |
| 08/04/2005 | WO2004043238A3 Biomarkers for intra-amniotic inflammation |
| 08/04/2005 | WO2004005316A3 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes |
| 08/04/2005 | WO2004003158A3 Methods and compositions for modulating and detecting wisp activity |
| 08/04/2005 | WO2003095610A3 Directed evolution method of generating enhanced folding polypeptide variants |
| 08/04/2005 | US20050172352 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease |
| 08/04/2005 | US20050172345 Recombinant cells comprising muscarinic acetylcholine receptor 6 for use in identifying modulators for prevention and treatment of muscle, eating and nervous system disorders |
| 08/04/2005 | US20050171339 Method of stabilizing protein |
| 08/04/2005 | US20050171336 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 08/04/2005 | US20050171024 Modulating angiogenesis |
| 08/04/2005 | US20050171018 Novel polypeptide and gene encoding the same |
| 08/04/2005 | US20050170468 Anti-IL-20 receptor antibodies and binding partners and methods of using in inflammation |
| 08/04/2005 | US20050170465 Nucleotide sequences coding transport proteins for identifying modulators for prevention and treatment of cell proliferative, nervous system, skin and inflammatory disorders |
| 08/04/2005 | US20050170464 Using microorgansim as bioreactor for propagating mutispecific immunoglobulin; immunotherapy; immunodiagnostics |
| 08/04/2005 | US20050170461 Identifying modulators which modify ligand protein binding for human pitutary and/or mouse pancreas-derived G protein-coupled receptorl treating nervous system and infectious disorders |
| 08/04/2005 | US20050170458 Inhibiting endothelial cell growth |
| 08/04/2005 | US20050170455 Novel prokineticin receptor isoforms and methods of use |
| 08/04/2005 | US20050170452 Method to engineer mammanlian-type carbohydrate structures |
| 08/04/2005 | US20050170451 Human type antihuman ige receptor antibody and fragment |
| 08/04/2005 | US20050170444 Detecting levels of free placental growth factor in urine samples; enzyme-lined immunosorbent assay, fluorescence polarization assay, or a colorimetric assay |
| 08/04/2005 | US20050170443 Methods and use of binding components for improving assay specificity |
| 08/04/2005 | US20050170440 Treatment and diagnosis of insulin-resistant states |
| 08/04/2005 | US20050170436 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 08/04/2005 | US20050170434 Modulators of lymphocyte activation, mkk3b compositions and methods of use |
| 08/04/2005 | US20050170431 PYK2 crystal structure and uses |
| 08/04/2005 | US20050170429 Method for monitoring collagen type II degradation in cartilage |
| 08/04/2005 | US20050170417 A mutated G-CSF protein having a deletion of an amino acid sequence corresponding to an exon 3 region for use as a diagnostic cancer marker. |
| 08/04/2005 | US20050170416 Accurate, economical and simple diagnosis of a variety of cancers based on the finding that exon 3 skipping occurs during transcription of the G-CSF gene in cancer patients |
| 08/04/2005 | US20050170414 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 08/04/2005 | US20050170411 Genes and proteins involved in the biosynthesis of enediyne ring structures |
| 08/04/2005 | US20050170407 Reagents and methods useful for detecting diseases of the lung |